ProstaLund
0,251
SEK
-3,09 %
PLUN
First North Stockholm
Medical Equipment & Services
Health Care
Vær den første som følger denne virksomhed
-3,09%
-16,33%
-30,85%
-54,18%
-83,98%
-84,59%
-94,33%
-91,21%
-97,25%
prostalund.se
ProstaLund operates in medical technology. Today, specialisation is mainly in the area of treatment of benign prostate enlargement (BPH). Through the company CoreTherm, heat treatment of benign prostate enlargement is offered, without the need for surgical operation. The vision is to offer both faster and more efficient solutions against traditional forms of infestation. The company was founded in 1991 and is operating globally, based in Lund.
Omsætning
22,21 mio.
EBIT %
-75,87 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
PLUN
Daglig lav / høj pris
0,251 / 0,251
SEK
Markedsværdi
36,39 mio. SEK
Aktieomsætning
251 SEK
Volumen
1 t
Finanskalender
Ekstraordinær generalforsamling
05.12.2024
Årsrapport
20.02.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| Mats Alyhr | 22,4 % | 22,4 % |
| Försäkringsaktiebolaget, Avanza pension | 9,0 % | 9,0 % |
| BFCM P/C BFCM Sweden Retail LT | 5,5 % | 5,5 % |
| Ålandsbanken | 3,3 % | 3,3 % |
| Nordnet Pensionsförsäkring | 2,8 % | 2,8 % |
| SEB Life International | 2,3 % | 2,3 % |
| Fenja Capital i A/S | 1,8 % | 1,8 % |
| Oskar Alyhr | 1,6 % | 1,6 % |
| Nilsson, Arve | 1,4 % | 1,4 % |
| Wiese, Hartmut | 1,3 % | 1,3 % |
ViserAlle indholdstyper
Interim report January-September 2024
Short-term results and long-term durability after CoreTherm® treatments presented at the Emirates International Urological Conference in Dubai, UAE
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools